Last update: February 24th 2015
February 18th 2015

EU Clinical Trials Regulation: EMA steers away...

Joint response to an EMA public consultation

The European Medicines Agency (EMA) must stay true to the Clinical Trials Regulation: non-disclosure has to remain the exception, not become the norm! 

Press release and joint response attached as PDF: 

February 10th 2015

European Directive on trade secrets: A threat...

Joint briefing paper

The proposed EU directive on the protection of trade secrets currently being studied by the European Parliament threatens freedom of speech for journalists and whistle-blowers, and access to scientific data of public interest.
Link to attached...

December 17th 2014

EU trade secrets directive a threat to health,...

Joint statement

The proposed trade secrets directive could obstruct recent EU developments on transparency and endangers freedom of information and expression of European citizens. A multi-sectoral NGO coalition calls for greater protections for consumers, journalists,...

November 28th 2014

European Medicines Agency (EMA) softens its...

28 November 2014 

Joint Press Release

At the end of November 2014, the European Medicines Agency has announced the adoption of a “more balanced approach to handling conflicts of interests” to become effective on 30 January 2015. In reality, this...

for members only



November 23th 2014


ISDB Publications

Manuals & booklets

October 01th 2008

ISDB Booklet

ISDB Information Booklet
Independence from drug companies is a key element of our policy

booklet october 2008 english (639 KB) - spanish (624 KB)

ISDB - International Society of Drug bullettins

Contact details:

© 2015